Cancer Metastasis Highlight Reel - Bioxytran $BIXT Takes on Cancer

(3:53)

BioXyTran ($BIXT) Investor Video

(4:14)

Bioxytran, Inc OTCQB BIXT

(31:34)

Bioxytran, Inc. (OTCQB: BIXT)

(33:15)

Emerging Growth Conference - Bioxytran $BIXT

(32:45)

BioXyTran ($BIXT) is Developing a Drug to Prevent Catastrophic Brain Damage from Strokes

(11:19)

BioXyTran ($BIXT) Interview at the Emerging Growth Conference

(40:56)

Bioxytran, Inc. (OTCQB: BIXT)

(33:10)

Episode #157: The Survival Paradox with Dr. Isaac Eliaz, MD, MS, LAc

(1:35:38)

Major News For Bioxytran’s BXT-25 | OTCMKTS: BIXT

(2:15)

Emerging Growth Conference 9/26/24

(33:45)

discovery of GB1211, a galectin-3 inhibitor - drug annotations

(17:)

March 2022 Functional Forum: Biotoxins and Tick-Borne Illnesses

(1:4:9)

Military Use of Universal Hemoglobin Based Oxygen Carrier w/ Freeze Dried Plasma (Blood Replacement)

(2:3)

Comparing Hyperbaric Oxygen Treatment (HBOT) to Hemoglobin Based BXT-25

(1:12)

About BioxyTran Inc, Emerging Growth Highlights Reel

(2:9)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Bioxytran, Inc. (OTCQB: BIXT)

(34:55)

BioXyTran ($BIXT) CEO, Dr. David Platt Interview

(11:2)

BFC LIVE w/Mike Sheikh of Bioxytran | $BIXT

(1:11:53)

Bioxytran's ($BIXT) Medical Breakthrough in Fighting All Viruses

(1:12)

Bioxytran (OTC: BIXT)

(40:56)

Bioxytran, Inc. (OTCQB: BIXT)

(33:47)

BioXyTran ($BIXT) Galectin Challenge Video

(1:3)

Buffalo Fireside Chats LIVE w Mike Sheikh of Bioxytran $BIXT

(1:11:53)

BioXyTran ($BIXT) in Advanced Talks to Take its Two Exciting Assets into the Clinic

(5:30)

BioXyTran ($BIXT) Interview with EVP Mike Sheikh - The Emerging Growth Conference

(39:36)

BioXyTran ($BIXT) Lead Drug-in-Development Looks to Help People Who Have Suffered a Stroke

(4:42)